POLRMT and non-small cell lung carcinoma: The use of POLRMT shRNA or CRISPR/Cas9 knockout (KO) effectively impeded mtDNA transcription and inhibited the growth of NSCLC cells in vitro and NSCLC xenografts in nude mice [17].